Literature DB >> 2763801

Experimental study on subacute neurotoxicity of methotrexate in cats.

M Shibutani1, R Okeda.   

Abstract

An experimental study on the pathogenesis of methotrexate (MTX)-related neurotoxicity including disseminated necrotizing leukoencephalopathy (DNL) was conducted in cats. MTX was administered to the cerebrospinal fluid (CSF) of adult cats using either an intracisternal intermittent instillation (ICI) model or an intraventricular continuous instillation (IVC) model. Furthermore, the synergistic effects of CSF-flow disturbance with kaolin-induced hydrocephalus, and 60Co irradiation were morphologically examined in these models. None of the animals from either the ICI and IVC groups showed DNL, but all animals showed segmental axonal degeneration, suggesting that MTX had a direct toxic effect on the axon. In the ICI groups, no apparent synergistic effect of CSF-flow disturbance and radiation was noted on this axonal change. In the IVC groups, CSF-flow disturbance augmented the degree of the axonal injury. Axonal degeneration and fibrin exudation in the walls of small blood vessels occurred in one animal of the IVC groups with CSF-flow disturbance, suggesting that a toxic effect of MTX on blood vessels is another mechanism of MTX-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2763801     DOI: 10.1007/BF00687759

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  31 in total

1.  Radioisotope ventriculography in cats with kaolin-induced hydrocephalus.

Authors:  H M Eisenberg; J E McLennan; K Welch; S Treves
Journal:  Radiology       Date:  1974-02       Impact factor: 11.105

2.  Prophylactic CNS therapy in childhood acute leukemia: review of methods used.

Authors:  C Pochedly
Journal:  Am J Pediatr Hematol Oncol       Date:  1979

3.  Proceedings: Parenchymatous degeneration of the central nervous system in childhood leukemia.

Authors:  B Hendin; D C DeVivo; R Torack; M E Lell; A H Ragab; T J Vietti
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

4.  Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.

Authors:  H Norrell; C B Wilson; D E Slagel; D B Clark
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

5.  The spinal cord central canal: response to experimental hydrocephalus and canal occlusion.

Authors:  D P Becker; J A Wilson; G W Watson
Journal:  J Neurosurg       Date:  1972-04       Impact factor: 5.115

6.  Current status of intrathecal chemotherapy for human meningeal neoplasms.

Authors:  W A Bleyer
Journal:  Natl Cancer Inst Monogr       Date:  1977-12

7.  Structural alterations in the spinal cord during progressive communicating syringomyelia. An experimental study in the cat.

Authors:  K Rascher; K H Booz; E Donauer; A C Nacimiento
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

8.  Effects of local irradiation and i.v. methotrexate on brain morphology in rabbits: early changes.

Authors:  R Ludwig; W Calvo; B Kober; W E Brandeis
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 9.  Histopathology of CNS leukemia and complications of therapy.

Authors:  R A Price
Journal:  Am J Pediatr Hematol Oncol       Date:  1979

10.  A study of experimental syringomyelia by scanning electron microscopy.

Authors:  P Hall; J Godersky; J Muller; R Campbell; J Kalsbeck
Journal:  Neurosurgery       Date:  1977 Jul-Aug       Impact factor: 4.654

View more
  7 in total

1.  Intracerebral (parenchymal) infusion of methotrexate: report of a case.

Authors:  K A Page; H Vogel; D S Horoupian
Journal:  J Neurooncol       Date:  1992-02       Impact factor: 4.130

2.  Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and alpha-fluoro-beta-alanine.

Authors:  R Okeda; M Shibutani; T Matsuo; T Kuroiwa; R Shimokawa; T Tajima
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Pediatric Acute Toxic Leukoencephalopathy: Prediction of the Clinical Outcome by FLAIR and DWI for Various Etiologies.

Authors:  K Ozturk; J Rykken; A M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

4.  Medication neurotoxicity in children.

Authors:  Ramesh S Iyer; Apeksha Chaturvedi; Sumit Pruthi; Paritosh C Khanna; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2011-07-23

5.  Methotrexate-related multifocal axonopathy. Report of an autopsy case.

Authors:  M Shibutani; R Okeda; A Hori; H Schipper
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy.

Authors:  M Oka; S Terae; R Kobayashi; Y Sawamura; K Kudoh; K K Tha; M Yoshida; M Kaneda; Y Suzuki; K Miyasaka
Journal:  Neuroradiology       Date:  2003-05-22       Impact factor: 2.804

Review 7.  Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features.

Authors:  Hamza Tariq; Andrea Gilbert; Francis E Sharkey
Journal:  Clin Med Insights Pathol       Date:  2018-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.